1003-3734
2012 Issue 11
Pharmaceutical care for inpatients with Parkinson’s disease
HE Zhong-fang1;WANG Tian-hong2;CHEN Jun2
HE Zhong-fang1;WANG Tian-hong2;CHEN Jun2
..............page:1306-1308
Influence of the time of middle cerebral artery occlusion on induction of cerebral ischemia-reperfusion injury in mice
CHEN Lan;CAO Liang-xun;QIAN Yi-song;GUAN Teng;HUANG Meng-hao;HUANG Long-fei;LI Yun-man
CHEN Lan;CAO Liang-xun;QIAN Yi-song;GUAN Teng;HUANG Meng-hao;HUANG Long-fei;LI Yun-man
..............page:1292-1295,1305
Protective effect of resveratrol on UVB irradiation-induced damage in human keratinocytes
WANG Jing-jing;CHE Ya-min;LIU Yuan-jun;WANG Lu;YAO Wei-feng;KE Wu-jian;LIU Quan-zhong
WANG Jing-jing;CHE Ya-min;LIU Yuan-jun;WANG Lu;YAO Wei-feng;KE Wu-jian;LIU Quan-zhong
..............page:1296-1300
Neuroprotective effect of Mailuoning on injury after oxygen glucose deprivation/reoxygenation in primary cultures of rat hippocampal neurons
RONG Guo-ling1;WU Shi-zheng2
RONG Guo-ling1;WU Shi-zheng2
..............page:1278-1282
Noninvasive photoacoustic tomography and its application prospect in neuropharmacology
ZHOU Jun-jun1;2;LI Chang-hui3;PU Xiao-ping1;2
ZHOU Jun-jun1;2;LI Chang-hui3;PU Xiao-ping1;2
..............page:1255-1259
..............page:1188
Protective effect of dihydrolycorine on H2O2-induced oxidative stress damage in PC12 cells
ZHANG Qiu-fang1;2;WANG Xuan-bin1;JI Yan-qiong3;WANG Shan-shan1; WANG Xian-lan1;DENG Wei1;LIU Ming1;LI Hong-liang1
ZHANG Qiu-fang1;2;WANG Xuan-bin1;JI Yan-qiong3;WANG Shan-shan1; WANG Xian-lan1;DENG Wei1;LIU Ming1;LI Hong-liang1
..............page:1288-1291
Dabigatran etexilate,a novel oral anticoagulant for stroke prevention in patients with atrial fibrillation
ZHANG Yin-xi;DING Mei-ping
ZHANG Yin-xi;DING Mei-ping
..............page:1227-1231,1236
Comparative study for retention rate of new antiepileptic drugs as an initial monotherapy in complex partial epilepsy
XU Fei;SUN Hong-bin
XU Fei;SUN Hong-bin
..............page:1265-1268
Protective effects of cysteinyl leukotriene receptor antagonists on ischemic brain injury
WEI Er-qing
WEI Er-qing
..............page:1250-1254
juan shou yu
wang yong jun
wang yong jun
..............page:1187
Epileptic seizures induced by imipenem/cilastatin sodium in an old patient: a case report
ZHAO Fa-guo;SHI jin;ZHANG Ying-qian
ZHAO Fa-guo;SHI jin;ZHANG Ying-qian
..............page:1309-1310
Biotechnology industry development: international experience and China selection
ZHANG Li1;ZHU Zhen-jia2
ZHANG Li1;ZHU Zhen-jia2
..............page:1195-1199,1219
..............page:1220-1223
..............page:1189-1190
Effect of echinacoside on monoamine neurotransmitters in bilateral brain tissue of rats with cerebral ischemia
ZHONG Ming1;CHEN Hong1;JIANG Yong2;TU Peng-fei2;LIU Chun-li1;WEI Li-li1
ZHONG Ming1;CHEN Hong1;JIANG Yong2;TU Peng-fei2;LIU Chun-li1;WEI Li-li1
..............page:1283-1287
Strategies for quality control of enoxaparin sodium
ZHANG Xiao-hong1;REN Lian-jie2;YU Li2;HUANG Xiao-long3;ZHAO Hui-ling3
ZHANG Xiao-hong1;REN Lian-jie2;YU Li2;HUANG Xiao-long3;ZHAO Hui-ling3
..............page:1200-1202
Research progress of the new anticoagulant drug rivaroxaban in the prevention of cerebral embolism in patients with atrial fibrillation
WANG Feng-zhi;HE Zhi-yi
WANG Feng-zhi;HE Zhi-yi
..............page:1224-1226
New oral anticoagulants in cardiovascular and cerebrovascular diseases
LI Shu-ya;DU Wan-liang;WANG Yong-jun
LI Shu-ya;DU Wan-liang;WANG Yong-jun
..............page:1191-1194,1209
Analysis of significant under-usage of warfarin in patients with nonvalvular atrial fibrillation
WANG Chun-juan1;WANG Chun-xue1;WANG Yong-jun1;WANG Yi-long1; ZHAO Xing-quan1;LIU Li-ping1;WANG David Z.2;LI Hao1;YANG Zhong-hua1
WANG Chun-juan1;WANG Chun-xue1;WANG Yong-jun1;WANG Yi-long1; ZHAO Xing-quan1;LIU Li-ping1;WANG David Z.2;LI Hao1;YANG Zhong-hua1
..............page:1203-1209
Comparison of the new oral anticoagulant drug with warfarin to prevent stroke in patients with atrial fibrillation
FANG Kun;CHENG Xin;DONG Qiang
FANG Kun;CHENG Xin;DONG Qiang
..............page:1214-1219
Phase Ⅰ tolerability trial of Shuluofenzhen
FENG Ping1;WANG Gang2;WU Song-ze1;ZHENG Li1;GOU Zhong-ping1; WANG Ying1;FENG Min1;XU Nan1
FENG Ping1;WANG Gang2;WU Song-ze1;ZHENG Li1;GOU Zhong-ping1; WANG Ying1;FENG Min1;XU Nan1
..............page:1260-1264,1282
..............page:1247-1249
Preparation and in vitro evaluation of ozagrel-loaded nanostructured lipid carriers
YANG Lei1;SHI Zhao-hui2;QIU Li-peng1;LI Lin1;WANG Dong-kai1
YANG Lei1;SHI Zhao-hui2;QIU Li-peng1;LI Lin1;WANG Dong-kai1
..............page:1301-1305
Advance in clinical study of platelet P2Y12 receptor antagonists
LIU Sheng-nan;ZHAO Zhi-gang
LIU Sheng-nan;ZHAO Zhi-gang
..............page:1241-1246,1254
A retrospective study on alteplase used for intravenous thrombolysis within 4.5 hours after cerebral infarction in primary hospitals
ZHU Bi-hong1;WANG Zhi-min1;HUANG Dan-jiang1;HAN Zhao2
ZHU Bi-hong1;WANG Zhi-min1;HUANG Dan-jiang1;HAN Zhao2
..............page:1269-1272,1277
Protective effect of Mailuoning on hypoxia-induced injury in human umbilical vein endothelial cells
LI Na1;WU Shi-zheng1;ZHANG Shu-kun2
LI Na1;WU Shi-zheng1;ZHANG Shu-kun2
..............page:1273-1277
Advances in clinical study of statin therapy for stroke
XIAO Li;CHEN Kang-ning
XIAO Li;CHEN Kang-ning
..............page:1232-1236
Protective effect of auraptene on cerebral ischemia-induced vascular dementia in rats
CHEN Hai-fang;LUO Li-ping;YUAN Jin-bin;LUO Xiao-quan;LI Zheng-hong;YANG Biao;YANG Wu-liang
CHEN Hai-fang;LUO Li-ping;YUAN Jin-bin;LUO Xiao-quan;LI Zheng-hong;YANG Biao;YANG Wu-liang
..............page:1210-1213
..............page:1237-1240